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Chronic rhinosinusitis is a disease of undefined etiology that significantly impacts the quality of 
life of its patients. Various studies carried out in countries other than Brazil have shown endoscopic 
sinus surgery as an effective means of treating this condition.
Objective: This study aims to analyze, with the aid of SNOT-20, the association between endoscopic 
sinus surgery and disease-specific quality of life of Brazilian patients treated for chronic rhinosinusitis 
accompanied or not by nasal polyps.
Materials and Methods: This prospective study enrolled patients submitted to endoscopic 
sinus surgery after drug therapy failed to improve their symptoms. They were assessed based on 
questionnaire SNOT-20p before and 12 months after surgery. Improvement on total scores and on 
the five items deemed more important by each patient were assessed. The study also looked into 
the correlation between preoperative scores and postoperative improvement and if there were any 
gender-related improvement differences.
Results: Forty-three patients aged 44 (19), md (IQR), 65% of whom (26/43) were males. Statistically 
significant improvement was seen on SNOT-20 and SNOT-20(5+) and a correlation was established 
between preoperative scores and postoperative improved scores (p<0.001). No gender-related 
differences were observed in quality of life.
Conclusion: Endoscopic sinus surgery in patients with chronic rhinosinusitis is associated with 
statistically significant improvements in disease-specific quality of life.
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INTRODUCTION
Rhinosinusitis (RS) is one of the most frequent 
complaints recorded in medical visits in North Ame-
rica. Some 14% of the US population is affected by 
this condition at an annual cost of USD 6 billion. It 
is one of the top reasons for prescribing antibiotics 
and for reduced worker productivity1-3. Chronic RS 
(CRS) cases can be divided into those in which nasal 
polyps are present and those in which they are not 
present. Patients are differentiated based on clinical 
examination, histopathologic findings, interleukin 
profile, and prognosis4. CRS is also closely related 
to endoscopic sinus surgery, as every year over 
200,000 procedures are carried out on the US alone5. 
Specific instruments to assess quality of life (QoL) 
connected to RS have been developed given the 
need to better evaluate morbidity, disease progress, 
and therapy impact.
Adequate validation of QoL questionnaires be-
fore they are used allows for comparisons between 
different populations. Quality of life questionnaire 
SNOT-20 (Sino-Nasal Outcome Test-20) was deve-
loped in 1998 to assess quality of life as it is specifi-
cally connected to rhinosinusitis, and has since then 
been used in most publications6,7. Another similar 
questionnaire validated in 2009 - SNOT-22 - is still 
targeted by some controversy8. The two questions 
added and presented as advantageous - olfactory 
and nasal obstruction assessment - may be much 
better evaluated by other instruments such as UPSIT 
and NOSE9,10. Another important fact to be conside-
red is the vastly greater possibilities of establishing 
comparisons between the outcomes of long term 
prognostic studies started with the SNOT-20.
The importance of comparing QoL between 
studies was shown by the “Medical Outcomes Study 
Short-Form 36-Item Health Survey” (SF-36), which 
revealed greater morbidity levels in bodily pain 
measurements and social function in patients with 
RS than in patients with congestive heart failure, 
angina, chronic obstructive pulmonary disease, and 
back pain. This study showed that the impact on 
patient QoL derived from RS is much greater than 
what is currently credited to this disease11.
A thorough and strict validation process for the 
Portuguese version of questionnaire SNOT-20 was 
recently published in an international journal with 
the participation of the author to the original ques-
tionnaire12. The process ensured that an adequate 
validation was produced, rather than a mere trans-
lation, and the participation of the questionnaire’s 
author in all stages of the process made sure that the 
questionnaire’s original intentions were preserved as 
set in the validation guidelines13. Another important 
factor to be considered is that the use of quality of 
life questionnaires has to be cleared by the institu-
tion responsible for the development of the original 
version in English, as they hold copyrights over it.
QoL measures validly and reliably connected 
to RS are crucial in the reassessment of RS treatment 
outcomes. For example, most studies showing the 
benefits of antibiotics used only patients’ descriptive 
reports of symptom improvement14. QoL is different 
from one’s health status. It is the unique personal 
experience that reflects not only one’s health status, 
but also other factors and circumstances pertaining 
to the patient’s life that only he/she can describe7.
Functional endoscopic sinus surgery (FESS) 
is the treatment of choice for CRS patients not res-
ponding to drug therapy3. To this date, no studies 
carried out in Brazil had looked into the association 
between FESS and QoL of CRS patients using a 
disease-specific questionnaire thoroughly adapted 
and validated for the Portuguese language.
This paper aims to assess the association 
between functional endoscopic sinus surgery and 
disease-specific quality of life of CRS patients throu-
gh questionnaire SNOT-20p.
MATERIALS AND METHODS
Study design
This prospective study was carried out be-
tween February of 2008 and October of 2010 at a 
tertiary care center. All patients signed an informed 
consent form as permitted by the Hospital Ethics 
Committee (no. 0522/08).
Patient sample
Patients were consecutively recruited from 
February of 2008 to October of 2009 and were 
followed for one year.
Enrollment criteria: CRS patients (as defined 
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by EPOS 2007) with or without nasal polyps who 
had not improved after three months of drug the-
rapy and referred to FESS3; age above 18 years; no 
pregnant/lactating patients; good overall health 
status; no systemic or localized diseases that might 
compromise the patient’s health. Exclusion criteria: 
previous endoscopic sinus surgery, secondary cau-
ses for CRS (fungus ball, invasive fungal disease, 
granuloma, vasculitis, isolated mucocele, nasal/
sinus malignant/benign tumor, congenital anoma-
lies - primary ciliary dyskinesia, cystic fibrosis - and 
oroantral fistula); congenital craniofacial anomalies; 
and primary/secondary immune deficiency.
Treatment
Patients underwent functional endoscopic 
sinus surgery as described by Messerklinger15, de-
pending on the extension of their main disease. They 
were given no medication preoperatively.
During postoperative care, all patients 
were given amoxicillin/clavulanate potassium 
500mg/125mg every 8 hours for 14 days, topical 
steroids, budesonide spray 64 mcg on each nostril 
every 12 hours for 12 months. Patients also used a 
nasal isotonic saline solution (NaCl 0.9%) 20 ml on 
each nostril every 6 hours until the surgical wound 
was completely healed and no crust was seen in the 
nasal cavity under endoscopic examination.
Patients were followed up during visits with 
a physician on the first day after surgery, weekly 
for the first month after surgery and then quarterly 
throughout the first year. Their postoperative status 
was assessed based on improvements on the com-
plaints present before surgery and bandages were 
put in place endoscopically with the aid of local 
anesthesia16. The patients in whom CRS still persisted 
one year after surgery were referred to a specific 
outpatient unit to be reassessed and to decide whe-
ther they should proceed with drug therapy or if a 
new procedure was recommended.
Endpoints
The endpoint looked at disease-specific QoL 
measured as a function of the total score and the 
score attained in the five items deemed more rele-
vant by each individual patient on the SNOT-20p 
questionnaire validated for the Portuguese langua-
ge12 before and 12 months after surgery.
Statistical analysis
Sample calculation was carried out considering 
an alpha value under 5% and a beta value under 20% 
for a standardized effect size of 0.5 and estimated 
loss of 25% with a total of 43 patients.
The data sets were analyzed using SPSS 10.0 
(SPSS Inc, Chicago, IL). The Kolgmorov-Smirnov test 
was used to assess goodness of fit in relation to the 
normal distribution. The Wilcoxon signed-rank test 
was used to compare questionnaire scores before 
and after surgery. We have also assessed the size of 
the effect of surgery upon disease-specific QoL. The 
correlation between preoperative scores and posto-
perative improvement was assessed and calculated 
by the difference between the postoperative and pre-
operative scores using Spearman’s rank correlation 
coefficient. We looked if there was any difference 
in QoL improvements in relation to gender using 
the Mann-Whitney U test. A p value under 5% was 
considered significant.
RESULTS
Forty-three patients with chronic rhinosinusi-
tis accompanied or not by nasal polyps submitted 
to FESS were included in the study; 90.7% (39/43) 
of them completed the study. Most patients were 
males [26/43 (60,5%)] with a median age of 44.0 
(interquartile range (IQR) =19).
A statistically significant reduction was seen 
between the scores attained pre and postoperatively 
on SNOT-20 [1.75 (IQR=2.05) vs. 0.90 (IQR=1.65), 
(p<0.001, Wilcoxon signed-rank test)] (Figure 1).
A statistically significant reduction was also 
observed in the scores of the five items deemed 
more relevant by the patients on SNOT-20 between 
the pre and postoperative times [4.00 (IQR=2.00) vs. 
1.20 (IQR=2.50), (p<0.001, Wilcoxon signed-rank 
test)] (Figure 2).
Surgery resulted in a standardized effect size 
of 1.13. Spearman’s rank correlation coefficient sho-
wed a moderate, statistically significant correlation 
between the preoperative total scores on the SNOT-
20 and postoperative improved scores (r=-0.547, 
p<0.001). According to the Mann-Whitney U test, 
no statistically significant differences were found 
on SNOT-20 scores of male and female patients 
(p=0.484) (Figure 3).
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This study presents a few limitations. One of 
them is the absence of a control group to preclude 
bias on patient improvement being influenced by 
the disease’s natural history in some cases or by a 
placebo effect in others. Nonetheless, all the patients 
who underwent surgery had already been submitted 
to longstanding drug therapy to no avail. Another is 
the fact that the study was carried out at a tertiary 
care unit. Our sample is usually made up of more 
complex cases. One of the ways of reducing bias 
was accepting only patients who had not been pre-
viously operated on.
Many are the positive things to be stressed in 
our study, such as its prospective design, the use 
of a properly adapted and validated assessment 
instrument, the assessment of results done from 
the standpoint of the patient, and a low rate of lost 
patients during follow-up. An important note: surge-
ons were blinded for preoperative SNOT-20 scores.
Many studies have shown the impact of FESS 
on QoL using disease-specific questionnaires, but 
to this date there had been no studies of this sort 
done in Brazil. A systematic review carried out in 
2005 found a number of papers from other countries 
that showed improved quality of life after FESS17. 
Two large prospective studies were done after this 
review by Ling et al.18 and Bhattacharyya et al.19 and 
also showed positive impacts on QoL after surgery. 
A large multicenter prospective study done in the 
United States published recently showed that 72% 
Figure 3. Differences in preoperative and postoperative scores on 
SNOT-20 between genders (p=0.484).
Figure 2. Preoperative and postoperative scores of the five items 
deemed more relevant by the patients on SNOT-20 (p<0.001).
Figure 1. Total preoperative and postoperative scores on SNOT-20 
(p<0.001).
DISCUSSION
Functional endoscopic sinus surgery had a 
positive association with CRS patients’ QoL as seen 
in the statistically significant difference observed 
in SNOT-20 scores before and after surgery [1.75 
(IQR=2.05) vs. 0.90 (IQR=1.65), (p<0.001)]. Our 
results have also shown a moderate, statistically 
significant correlation between higher preoperati-
ve scores and greater reduction on postoperative 
scores, indicative of greater impact on the QoL of 
the patients with the worse QoL before surgery (r=-
0.547, p<0.001).
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to 76% of the patients had significant clinical im-
provements on disease-specific QoL after surgery20. 
The results from our sample of patients matched 
the results found by the author in the development 
of the original questionnaire and those of a similar 
study carried out in Germany7,21. Only two clinical 
trials were found in the literature comparing surgery 
to drug therapy. Neither showed statistically signifi-
cant differences. However, none of them followed 
the patients after the cessation of drug therapy22,23.
Many studies done in the past to assess the 
effectiveness of FESS in the treatment of chronic rhi-
nosinusitis patients used non-validated QoL questio-
nnaires and looked into the presence or absence of 
certain symptoms, alterations viewed endoscopically 
or on CT scans24-26. The results of these studies could 
not be used to compare populations and were hard 
to interpret. Physical examination findings may often 
be biased by subjectivity or simply not be correlated 
to the actual status of diseased patients.
Changes on endoscopic examination of CRS 
patients can be correlated to QoL, although posto-
perative nasal/sinus improvement may explain for 
only a small portion of the QoL improvement seen 
after FESS27. Improvements on CRS patient symptoms 
or QoL after FESS are very weakly correlated to CT 
findings28.
The validated disease-specific QoL questio-
nnaire for CRS patients - SNOT-20 - has been the 
most widely used of its kind in the world and has 
now been validated in the Portuguese language12. 
An available valid questionnaire will allow the re-
sults of the studies done in Brazil to be compared to 
the results of studies carried out all over the world 
to assess the impact on disease-specific QoL. This 
questionnaire is also correlated to patient global QoL 
(SF-36) and the visual analogue scale28.
There are other validated instruments to assess 
the impact of nasal/sinus complaints upon QoL. 
The RSOM-31 (Rhinosinusitis outcome measure) 
contains 31 questions divided into seven subsets; 
however, the scale onto which the answers have 
been placed make it somewhat hard to answer29. 
The RSDI (Rhinosinusitis Disability Index) relates 
nasal/sinus symptoms to specific limitations placed 
upon daily life activities through 30 questions in a 
similar fashion to the RSOM30. The RQLQ (Rhinocon-
junctivitis quality of life questionnaire) is directed to 
allergy symptoms of a nasal/sinus nature, but it has 
not been validated for rhinosinusitis31.
The SNOT-20 is a simplification of the RSOM-
31 in which 11 items have been removed due to 
redundancy or simply because they did not add 
significant value to the instrument. The scoring sys-
tem for answers and calculation formula to obtain 
the result of the questionnaire were simplified. The 
five patient-selected items make up a second score7.
The recently validated8 SNOT-22 is made up 
by the simple summation of olfactory and nasal 
obstruction scores on the SNOT-20. It is an impor-
tant tool, but we believe that in most prospective 
studies it would be more advantageous to assess 
olfaction using specific tests such as the UPSIT10 
and to evaluate nasal obstruction using the NOSE9 
questionnaire.
The UPSIT allows for a broader assessment of 
hyposmia rather than through only one question. 
Soter et al.32 have shown that the UPSIT is much 
superior than the simple perception patients have 
over their sense of smell. The completion of the 
validation process of the UPSIT test (“University 
of Pennsylvania Smell Identification Test”) for the 
Portuguese language, by Fornazieri et al.10, will 
allow a more objective and specific assessment of 
our patients’ olfaction. The questionnaire that was 
in use in Brazil contained a few glitches, and the 
transcultural adaptation process will aim at produ-
cing a version that is closer to our reality.
We have been using a Portuguese-validated, 
accepted-for-publication version of the NOSE (Nasal 
Obstruction Symptom Evaluation)9 to assess QoL 
specifically connected to nasal obstruction, as it 
assesses complaints of this nature in a multifaceted 
manner. It is a free instrument. The NOSE allows 
the analysis of other facets pertaining to nasal obs-
truction, as patients are often not bothered or fail to 
complain specifically about it, though they mention 
nasal congestion or difficulty breathing through 
the nose. We have opted for the use of this easy-
-to-use instrument in our studies because it looks 
into such complaints more thoroughly in only two 
minutes. It can be used to assess any nasal disease 
associated with this complaint, and not only chronic 
rhinosinusitis.
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We are not suggesting that CRS patients should 
not be asked these questions. We are only indicating 
that these two items can be analyzed in more detail 
through UPSIT and NOSE, instead of the simple 
addition of two questions. These instruments are 
used mainly for research, not in our daily practice; 
from the standpoint of research method, it would be 
better to use NOSE and UPSIT than merely adding 
these two questions.
CONCLUSION
Functional endoscopic sinus surgery done in 
patients with chronic rhinosinusitis in Brazil has been 
associated with statistically significant improvements 
on disease-specific QoL for patients followed for 
one year. Future clinical trials carried out in Brazil 
will add to the scientific evidence gathered on the 
effectiveness of surgery offered to our population, as 
seen in studies performed in other countries.
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